Macrocyclic inhibitor for hepatitis C

Nature Reviews Drug Discovery

Volumn 2, Issue 12, 2003, Pages 945-

  Brazil, Melanie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANTIVIRUS AGENT; CILUPREVIR; MACROCYCLIC COMPOUND; PLACEBO; SERINE PROTEINASE; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; CLINICAL STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG SPECIFICITY; DRUG TARGETING; DRUG TOLERABILITY; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; SIDE EFFECT; STRUCTURE ACTIVITY RELATION; VIRUS LOAD; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0346328269     PISSN: 14741776     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrd1259     Document Type: Note

References (1)

1. Lamarre, D. et al. An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus. Nature 426, 186-189 (2003)